Archives
-
Maridomycin: In Vitro and In Vivo Antibacterial Activity
2026-09-24
Kondo and colleagues characterized maridomycin through susceptibility testing, resistance selection, activity assays, protein-binding measurements, and mouse infection experiments. Their findings define important assay-dependent effects—including greater activity at alkaline pH and reduced activity with larger inocula—while placing maridomycin’s spectrum and resistance profile in the context of the related macrolide leucomycin.
-
L-Glutathione Reduced for Redox Assays
2026-09-24
A practical guide to using L-Glutathione Reduced (SKU B7775) in cell viability and redox experiments, with handling details and interpretation cautions. Connects reduced glutathione controls to GOT1-linked pancreatic cancer research without treating a redox response as proof of mechanism.
-
VE-821 and ATR: Translational Logic Beyond Checkpoints
2026-09-23
A translational framework for using VE-821 to interrogate ATR checkpoint biology, design radiosensitization and chemotherapy-sensitization experiments, and interpret epigenetic findings without conflating distinct pathways.
-
Caspase-8 in Hyperthermia–Cisplatin Cancer Therapy
2026-09-23
A 2024 study shows that hyperthermia enhances cisplatin-induced cancer cell death by promoting caspase-8 accumulation, K63-linked polyubiquitination, and activation. The resulting signaling connects caspase-8 with both apoptosis and pyroptosis, providing a mechanistic framework for interpreting combination-treatment responses.
-
Mianserin HCl: From Receptors to Translation
2026-09-22
Mianserin HCl is more than a 5-HT2 receptor antagonist: it is a translational antidepressant research compound linking receptor pharmacology, plasma exposure, formulation, and antipathogenic hypotheses. This article explains how to interpret those evidence streams without confusing assay activity with clinical proof.
-
Monomeric Aβ and Microglial Inflammation in the Brain
2026-09-22
This preprint identifies an APP and heterotrimeric G protein pathway through which monomeric amyloid-β suppresses inflammatory activity in brain microglia. Its findings connect microglial regulation with cortical development and provide a mechanistic framework for interpreting how amyloid-β molecular state may influence Alzheimer's disease biology.
-
Amyloid Beta-Peptide (1-40): Calcium-Aware Assays
2026-09-21
Amyloid Beta-Peptide (1-40) (human) enables calcium-aware studies of membrane binding, aggregation, and neurotoxicity. This guide translates supercritical-angle spectroscopy findings into practical decisions for Alzheimer's disease research assays.
-
Deuterium-Labeled Degarelix: Synthesis and Significance
2026-09-21
The reference study describes a practical 13-step synthesis of deuterium-labeled degarelix acetate, using early D2O/D3PO4-mediated labeling of a naphthyl amino acid before Fmoc-based peptide assembly. Its main contribution is a usable isotopologue route that produced an internal standard for future degarelix absorption, distribution, metabolism, and excretion studies.
-
Aβ42 Beyond Plaques: Designing Translational Models
2026-09-20
A mechanistic guide to using Amyloid β-Peptide (1-42) in Alzheimer’s disease research, linking aggregation state, microglial phagocytosis, neuronal toxicity, and ion-channel biology to more predictive translational workflows.
-
FPS-ZM1: A Practical RAGE Inhibitor Workflow
2026-09-19
Use FPS-ZM1 as a selective mechanistic probe to separate RAGE-driven effects from broader metabolic or anti-inflammatory actions. This workflow connects hypothalamic RAGE/POMC studies with amyloid beta transport, neuronal stress, and neuroinflammation assays while keeping preclinical evidence and clinical expectations distinct.
-
CNO and Circuit Precision in Translational Neuroscience
2026-09-18
Clozapine N-oxide is more than a DREADDs activator: it is a strategic tool for testing how defined inhibitory microcircuits shape stress-related behavior. This article connects CNO-enabled neuronal activity modulation with basolateral amygdala biology, experimental controls, translational maturity, and reproducible workflow design.
-
GOB-38 in Elizabethkingia anophelis: Study Insights
2026-09-18
The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from Elizabethkingia anophelis, and shows that its substrate profile spans penicillins, cephalosporins, and carbapenems. Its combination of recombinant enzyme analysis, comparative genomics, and co-culture experiments clarifies how this enzyme may contribute to β-lactam resistance and highlights the need for substrate-specific validation.
-
Nanoparticle Uptake in Human Corneal Epithelial Cells
2026-09-17
Azadi and David developed a controlled PLGA nanoparticle platform to determine how particle size and surface chemistry affect uptake by human corneal epithelial cells. Their results identify energy-dependent endocytosis, particularly macropinocytosis and caveolae-mediated uptake, as the dominant mechanisms under the tested conditions and provide design guidance for topical ocular delivery.
-
Caffeic Acid Phenethyl Ester for NF-κB Assays
2026-09-17
CAPE is a practical NF-κB pathway probe for connecting inflammatory signaling with angiogenesis, invasion, and neurodegeneration workflows. Its strongest use is as one component of a controlled assay panel that combines pathway, viability, cytokine, and disease-relevant phenotypes.
-
FPS-ZM1: From RAGE Target to Causal Assay
2026-09-16
FPS-ZM1 is a selective RAGE inhibitor for dissecting amyloid beta signaling, neuroinflammation, and emerging RAGE/POMC biology. This article translates recent berberine research into a rigorous assay strategy while separating established evidence from testable hypotheses.